Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.72 | N/A |
| PEG Ratio (TTM) | 39.66 | N/A |
| P/S Ratio (TTM) | 2.05 | N/A |
| P/B Ratio (TTM) | 1.34 | N/A |
| P/FCF Ratio (TTM) | 10.80 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.63 | N/A |
| Price to 5YR AVG FCF Ratio | 11.35 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.76% | N/A |
| ROE (TTM) | 10.48% | N/A |
| Net Profit Margin (TTM) | 14.94% | N/A |
| ROIC 5YR AVG | 25.32% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.08% | 13.80% | 6.01% |
| Revenue | 9.81% | 9.74% | 6.14% |
| Net Income | 1.48% | 14.82% | 6.97% |
| Cash Flow | 85.07% | 17.04% | 9.46% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.27 | N/A |
| Quick Ratio (TTM) | 0.27 | N/A |
| D/E Ratio (TTM) | 0.33 | N/A |
| Interest Coverage (TTM) | 0.83 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 2.07 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.92% | N/A |